scholarly journals DisruptingTP53 in mouse models of human cancers

2003 ◽  
Vol 21 (3) ◽  
pp. 321-326 ◽  
Author(s):  
John M. Parant ◽  
Guillermina Lozano
Keyword(s):  
2011 ◽  
Vol 29 (16) ◽  
pp. 2273-2281 ◽  
Author(s):  
Katerina Politi ◽  
William Pao

Genetically engineered mouse models (GEMMs) of human cancer were first created nearly 30 years ago. These early transgenic models demonstrated that mouse cells could be transformed in vivo by expression of an oncogene. A new field emerged, dedicated to generating and using mouse models of human cancer to address a wide variety of questions in cancer biology. The aim of this review is to highlight the contributions of mouse models to the diagnosis and treatment of human cancers. Because of the breadth of the topic, we have selected representative examples of how GEMMs are clinically relevant rather than provided an exhaustive list of experiments. Today, as detailed here, sophisticated mouse models are being created to study many aspects of cancer biology, including but not limited to mechanisms of sensitivity and resistance to drug treatment, oncogene cooperation, early detection, and metastasis. Alternatives to GEMMs, such as chemically induced or spontaneous tumor models, are not discussed in this review.


2011 ◽  
Vol 13 (7) ◽  
pp. 692-699 ◽  
Author(s):  
D. H. Gutmann ◽  
C. D. Stiles ◽  
S. W. Lowe ◽  
G. E. Bollag ◽  
F. B. Furnari ◽  
...  

2015 ◽  
Vol 8s1 ◽  
pp. CGM.S21218 ◽  
Author(s):  
Marie-Pier Tétreault

Esophageal cancer is the eighth leading cause of cancer and the sixth most common cause of cancer-related death worldwide. Despite recent advances in the development of surgical techniques in combination with the use of radiotherapy and chemotherapy, the prognosis for esophageal cancer remains poor. The cellular and molecular mechanisms that drive the pathogenesis of esophageal cancer are still poorly understood. Hence, understanding these mechanisms is crucial to improving outcomes for patients with esophageal cancer. Mouse models constitute valuable tools for modeling human cancers and for the preclinical testing of therapeutic strategies in a manner not possible in human subjects. Mice are excellent models for studying human cancers because they are similar to humans at the physiological and molecular levels and because they have a shorter gestation time and life cycle. Moreover, a wide range of well-developed technologies for introducing genetic modifications into mice are currently available. In this review, we describe how different mouse models are used to study esophageal cancer.


2017 ◽  
Vol 46 (D1) ◽  
pp. D1011-D1017 ◽  
Author(s):  
Justin Y Newberg ◽  
Karen M Mann ◽  
Michael B Mann ◽  
Nancy A Jenkins ◽  
Neal G Copeland

2006 ◽  
Vol 203 (5) ◽  
pp. 1143-1145 ◽  
Author(s):  
Steven E. Artandi

Telomerase, the enzyme that elongates our telomeres, is crucial for cancer development based on extensive analyses of human cells, human cancers, and mouse models. New data now suggest that a viral telomerase RNA gene encoded by Marek's disease virus (MDV), an oncogenic herpesvirus of chickens, promotes tumor formation. These findings highlight the importance of telomerase in cancer and raise new questions regarding the mechanisms by which the telomerase RNA component supports tumorigenesis.


2013 ◽  
Vol 73 (9) ◽  
pp. 2718-2736 ◽  
Author(s):  
Michael Ittmann ◽  
Jiaoti Huang ◽  
Enrico Radaelli ◽  
Philip Martin ◽  
Sabina Signoretti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document